569 related articles for article (PubMed ID: 31774228)
1. Soluble urokinase plasminogen activator receptor associates with higher risk, advanced disease severity as well as inflammation, and might serve as a prognostic biomarker of severe acute pancreatitis.
Zhang Q; Li L; Chen H; Zhang G; Zhu S; Kong R; Chen H; Wang G; Sun B
J Clin Lab Anal; 2020 Mar; 34(3):e23097. PubMed ID: 31774228
[TBL] [Abstract][Full Text] [Related]
2. Soluble urokinase-type plasminogen activator receptor (suPAR) in patients with acute pancreatitis (AP) - Progress in prediction of AP severity.
Lipinski M; Rydzewska-Rosolowska A; Rydzewski A; Cicha M; Rydzewska G
Pancreatology; 2017; 17(1):24-29. PubMed ID: 27914940
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of long non-coding RNA intersectin 1-2 for occurrence and in-hospital mortality of severe acute pancreatitis.
Li J; Bu X; Chen X; Xiong P; Chen Z; Yu L
J Clin Lab Anal; 2020 May; 34(5):e23170. PubMed ID: 31880027
[TBL] [Abstract][Full Text] [Related]
4. Plasma level of soluble urokinase plasminogen activator receptor (suPAR) predicts long-term mortality after first acute alcohol-induced pancreatitis.
Aronen A; Aittoniemi J; Huttunen R; Nikkola A; Nikkola J; Limnell O; Nordback I; Sand J; Laukkarinen J
Eur J Intern Med; 2019 Jun; 64():72-75. PubMed ID: 31060962
[TBL] [Abstract][Full Text] [Related]
5. Plasma Level of Soluble Urokinase-type Plasminogen Activator Receptor Predicts the Severity of Acute Alcohol Pancreatitis.
Nikkola A; Aittoniemi J; Huttunen R; Rajala L; Nordback I; Sand J; Laukkarinen J
Pancreas; 2017 Jan; 46(1):77-82. PubMed ID: 27841794
[TBL] [Abstract][Full Text] [Related]
6. Circulating microRNA-146a and microRNA-146b exhibit potential to serve as markers for acute pancreatitis management and prognosis.
Li XY; Wang YF; Li N
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12770-12780. PubMed ID: 33378026
[TBL] [Abstract][Full Text] [Related]
7. Combining National Early Warning Score With Soluble Urokinase Plasminogen Activator Receptor (suPAR) Improves Risk Prediction in Acute Medical Patients: A Registry-Based Cohort Study.
Rasmussen LJH; Ladelund S; Haupt TH; Ellekilde GE; Eugen-Olsen J; Andersen O
Crit Care Med; 2018 Dec; 46(12):1961-1968. PubMed ID: 30247244
[TBL] [Abstract][Full Text] [Related]
8. Severity stratification and prognostic prediction of patients with acute pancreatitis at early phase: A retrospective study.
Zhou H; Mei X; He X; Lan T; Guo S
Medicine (Baltimore); 2019 Apr; 98(16):e15275. PubMed ID: 31008971
[TBL] [Abstract][Full Text] [Related]
9. Clinical value of soluble urokinase-type plasminogen activator receptor in the diagnosis, prognosis, and therapeutic guidance of sepsis.
Zeng M; Chang M; Zheng H; Li B; Chen Y; He W; Huang C
Am J Emerg Med; 2016 Mar; 34(3):375-80. PubMed ID: 26615223
[TBL] [Abstract][Full Text] [Related]
10. The predictive value of soluble urokinase plasminogen activator receptor (SuPAR) regarding 90-day mortality and 12-month neurological outcome in critically ill patients after out-of-hospital cardiac arrest. Data from the prospective FINNRESUSCI study.
Jalkanen V; Vaahersalo J; Pettilä V; Kurola J; Varpula T; Tiainen M; Huhtala H; Alaspää A; Hovilehto S; Kiviniemi O; Kuitunen A; Tenhunen J;
Resuscitation; 2014 Nov; 85(11):1562-7. PubMed ID: 25193800
[TBL] [Abstract][Full Text] [Related]
11. Blood suPAR, Th1 and Th17 cell may serve as potential biomarkers for elderly sepsis management.
Zhao L; Yu S; Wang L; Zhang X; Hou J; Li X
Scand J Clin Lab Invest; 2021 Oct; 81(6):488-493. PubMed ID: 34369213
[TBL] [Abstract][Full Text] [Related]
12. Soluble urokinase plasminogen activator receptor is compartmentally regulated in decompensated cirrhosis and indicates immune activation and short-term mortality.
Zimmermann HW; Reuken PA; Koch A; Bartneck M; Adams DH; Trautwein C; Stallmach A; Tacke F; Bruns T
J Intern Med; 2013 Jul; 274(1):86-100. PubMed ID: 23432143
[TBL] [Abstract][Full Text] [Related]
13. Soluble Urokinase Plasminogen Activator Receptor: A New Biomarker in the Pediatric Intensive Care Unit.
El-Mekkawy MS; Saleh NY; Sonbol AA
Indian J Pediatr; 2016 Jul; 83(7):661-9. PubMed ID: 26960717
[TBL] [Abstract][Full Text] [Related]
14. Soluble urokinase plasminogen activator receptor (suPAR) in acute care: a strong marker of disease presence and severity, readmission and mortality. A retrospective cohort study.
Rasmussen LJ; Ladelund S; Haupt TH; Ellekilde G; Poulsen JH; Iversen K; Eugen-Olsen J; Andersen O
Emerg Med J; 2016 Nov; 33(11):769-775. PubMed ID: 27590986
[TBL] [Abstract][Full Text] [Related]
15. Risk Factors for Worsening of Acute Pancreatitis in Patients Admitted with Mild Acute Pancreatitis.
Jin Z; Xu L; Wang X; Yang D
Med Sci Monit; 2017 Feb; 23():1026-1032. PubMed ID: 28238002
[TBL] [Abstract][Full Text] [Related]
16. Plasma suPAR as a prognostic biological marker for ICU mortality in ARDS patients.
Geboers DG; de Beer FM; Tuip-de Boer AM; van der Poll T; Horn J; Cremer OL; Bonten MJ; Ong DS; Schultz MJ; Bos LD
Intensive Care Med; 2015 Jul; 41(7):1281-90. PubMed ID: 26100127
[TBL] [Abstract][Full Text] [Related]
17. Soluble urokinase plasminogen activator receptor predicts mortality in patients with systemic inflammatory response syndrome.
Raggam RB; Wagner J; Prüller F; Grisold A; Leitner E; Zollner-Schwetz I; Valentin T; Krause R; Hoenigl M
J Intern Med; 2014 Dec; 276(6):651-8. PubMed ID: 24645798
[TBL] [Abstract][Full Text] [Related]
18. Early Prediction of Persistent Organ Failure by Serum Angiopoietin-2 in Patients with Acute Pancreatitis.
Zhang YP; Liu C; Ye L; Yu N; Ye YN; Sun WR; Wu L; Wang FY
Dig Dis Sci; 2016 Dec; 61(12):3584-3591. PubMed ID: 27686934
[TBL] [Abstract][Full Text] [Related]
19. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
Enocsson H; Wetterö J; Skogh T; Sjöwall C
Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
[TBL] [Abstract][Full Text] [Related]
20. BISAP, RANSON, lactate and others biomarkers in prediction of severe acute pancreatitis in a European cohort.
Valverde-López F; Matas-Cobos AM; Alegría-Motte C; Jiménez-Rosales R; Úbeda-Muñoz M; Redondo-Cerezo E
J Gastroenterol Hepatol; 2017 Sep; 32(9):1649-1656. PubMed ID: 28207167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
